Lifecore Biomedical Inc (LFCR)
5.85
+0.08
(+1.39%)
USD |
NASDAQ |
May 17, 16:00
5.85
0.00 (0.00%)
After-Hours: 20:00
Lifecore Biomedical Cash from Financing (Quarterly): 40.93M for May 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2023 | 24.57M |
| February 28, 2023 | 2.414M |
| November 30, 2022 | 8.809M |
| August 31, 2022 | 3.906M |
| May 31, 2022 | 19.14M |
| February 28, 2022 | -47.09M |
| November 30, 2021 | 9.878M |
| August 31, 2021 | -38.95M |
| May 31, 2021 | 6.988M |
| February 28, 2021 | 11.59M |
| November 30, 2020 | -4.972M |
| August 31, 2020 | -17.02M |
| May 31, 2020 | 15.02M |
| February 29, 2020 | -6.077M |
| November 30, 2019 | 15.06M |
| August 31, 2019 | 16.02M |
| May 31, 2019 | 5.211M |
| February 28, 2019 | 61.60M |
| November 30, 2018 | 1.491M |
| August 31, 2018 | 10.72M |
| May 31, 2018 | 8.605M |
| February 28, 2018 | 0.60M |
| November 30, 2017 | -2.114M |
| August 31, 2017 | 6.201M |
| May 31, 2017 | 2.126M |
| Date | Value |
|---|---|
| February 28, 2017 | -2.796M |
| November 30, 2016 | -2.518M |
| August 31, 2016 | -5.613M |
| May 31, 2016 | 0.884M |
| February 29, 2016 | 9.011M |
| November 30, 2015 | 7.391M |
| August 31, 2015 | -1.863M |
| May 31, 2015 | -7.65M |
| February 28, 2015 | 2.844M |
| November 30, 2014 | 7.071M |
| August 31, 2014 | 5.441M |
| May 31, 2014 | -1.261M |
| February 28, 2014 | 0.191M |
| November 30, 2013 | -0.847M |
| August 31, 2013 | -5.262M |
| May 31, 2013 | -1.886M |
| February 28, 2013 | -2.915M |
| November 30, 2012 | -0.038M |
| August 31, 2012 | -14.43M |
| May 31, 2012 | 39.21M |
| February 29, 2012 | 0.73M |
| November 30, 2011 | -4.302M |
| August 31, 2011 | 0.298M |
| May 31, 2011 | -2.402M |
| February 28, 2011 | -0.546M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-47.09M
Minimum
Feb 2022
24.57M
Maximum
May 2023
1.440M
Average
6.988M
Median
May 2021
Cash from Financing (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 81.74M |
| SELLAS Life Sciences Group Inc | 26.65M |
| ADMA Biologics Inc | -1.447M |
| Relmada Therapeutics Inc | 0.2217M |
| Jaguar Health Inc | 12.27M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.29M |
| Cash from Investing (Quarterly) | -7.50M |